8-K filing — UPEXI, INC. (UPXI)
Filed: 2026-09-17 AccNo: 0001477932-26-005669 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Full Transcript: Upexi Q4 2026 Earnings Call
Upexi (NASDAQ:UPXI) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Upexi Q4 EPS $(0.21) Misses $(0.12) Estimate, Sales $3.149M Miss $7.572M Estimate
Upexi (NASDAQ:UPXI) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 75 percent. This is a 16 percent increase over losses of $(0.25) per share from the same
Earnings Scheduled For September 17, 2026
Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. • Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10